A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel

PHASE3CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Adult Male Hypogonadism
Interventions
DRUG

Testosterone Gel (FE 999093)

Trial Locations (18)

Unknown

Medical Affiliated Research Center, Huntsville

California Professional Research, Newport Beach

San Diego Sexual Medicine, San Diego

Connecticut Clinical Research, Middlebury

South Florida Medical Research, Aventura

Michigan Institute of Urology, Saint Clair Shores

Premier Urology Associates, Lawrenceville

University Urology, New York

Premier Medical Group of the Hudson Valley, Poughkeepsie

PMG Research of Wilmington, Winston-Salem

Tristate Urologic Services, Cincinnati

Omega Medical Research, Warwick

Coastal Carolina Research Center, Mt. Pleasant

Carolina Urologic Research Center, Myrtle Beach

Clinical Research Associates, Nashville

Urology Clinics of North Texas, Dallas

St. Joseph's Healthcare, London

Private Practice and Clinical Research, North Bay

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT01703741 - A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel | Biotech Hunter | Biotech Hunter